NCT06914622

Brief Summary

The project focuses on patients with severe mental disorders (SMD) residing in Italian mental health supported accommodation (SA). Although the goal of SA is to promote personal recovery - that is, living life to the fullest of one's potential - international literature on this topic is scarce, and traditional treatments in the Italian residential system show limitations in adopting such approaches. The research hypothesis is that activating personal recovery pathways could improve the biopsychosocial outcomes of patients, caregivers, and professionals. To test this hypothesis, a non-pharmacological, non-randomized interventional trial will compare two groups: one group of individuals with SMD receiving recovery-oriented treatment, using the Mental Health Recovery Star, and another group of individuals with SMD receiving standard treatment. The Mental Health Recovery Star is a ten-pointed star-shaped tool that represents various life dimensions. Patients, together with their key professional, are expected to negotiate a score for each domain on the five-stage 'Scale of Change,' capturing and monitoring the different phases of the recovery process.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Jan 2026

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Jan 2026Dec 2028

First Submitted

Initial submission to the registry

March 24, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 6, 2025

Completed
9 months until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

March 24, 2025

Last Update Submit

December 11, 2025

Conditions

Keywords

mental health supported accommodationpersonal recoverysevere mental disorderbio-psychosocialrehabilitation

Outcome Measures

Primary Outcomes (1)

  • Psychosocial functioning

    Personal and Social Functioning Scale (FPS): assesses four key domains (socially useful activities, personal and social relationships, self-care and hygiene, and disruptive/aggressive behaviors) with scores ranging from 0 to 100, where higher scores indicate better functioning.

    at baseline and at 6 and 9 months follow-up

Secondary Outcomes (30)

  • Rehabilitation goals

    at baseline and at 6-9 months follow-up

  • Stress-related parameters

    at baseline and at 6-9 months follow-up

  • Real-time experiences

    at baseline and at 6-9 months follow-up for 1 week, and partly for 6 months along the experimental or control treatment

  • Physical Activity-Related Parameters

    for 1 week at baseline and at 6-9 months follow-up

  • Working alliance

    at baseline and at 6-9 months follow-up

  • +25 more secondary outcomes

Study Arms (2)

Recovery-oriented treatment

EXPERIMENTAL

A group of residents will receive a personal recovery-oriented treatment (N=36) whose key professionals have participated in specific training on personal recovery.

Behavioral: Mental Health Recovery Star (MHRS)

Standard treatment

NO INTERVENTION

A group of residents will receive standard treatment (N=36). Standard residential treatment for individuals with mental disorders includes medical, psychological, and social interventions aimed at improving symptoms, quality of life, and functioning. The approach is personalized based on the individual's diagnosis, symptoms, and community resources. Most SAs offer personalized care plans, designated key professionals, regular individual and group activities, medication management support, and healthy lifestyle promotion. However, few facilities provide continuous psychological, vocational, and social support, adequately addressing patients' real needs.

Interventions

The personal recovery-oriented treatment is the Mental Health Recovery Star (MHRS), a recovery-oriented tool developed in England to support and monitor personal recovery. It features a 10-point star representing life dimensions grouped into four areas: health, functioning, self-image, and social networks. Residents assess their progress on each point using a "Scale of Change " with five recovery stages, from feeling stuck to self-reliance. After assessment, residents and professionals set recovery goals (up to three at a time) and create a shared care plan. The MHRS shows good psychometric properties, with strong validity, consistency, and ease of use, despite some inter-rater reliability issues. It is best suited for shared rehabilitation plans rather than clinical monitoring. Peer review meetings will be provided. The personal recovery-oriented treatment will last six months and will be considered complete upon follow-up evaluation.

Recovery-oriented treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of a mental disorder according to DSM5TR,
  • receiving treatment at an SRP of the recruiting centers,

You may not qualify if:

  • moderate/severe intellectual disability,
  • inability to speak and write in Italian.
  • over 18 years old,
  • inability to speak and write in Italian.
  • working in SRPs of the recruiting centers as a psychiatrist, educator, nurse, social worker, OSS, ASA, or TeRP,
  • unwillingness to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

IRCCS Centro San Giovanni di Dio Fatebenefratelli

Brescia, Italy

RECRUITING

Centro Sacro Cuore di Gesù, San Colombano al Lambro (MI)

Milan, Italy

RECRUITING

Centro Sant'Ambrogio, Cernusco sul Naviglio (MI)

Milan, Italy

RECRUITING

MeSH Terms

Conditions

Mental Disorders

Study Officials

  • Alessandra Martinelli, MD PhD

    IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alessandra Martinelli, MD PhD

CONTACT

Amalia Research Office Manager, Morelli

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study design is a non-randomized clinical trial. A group of residents receiving personal recovery-oriented treatment (N=36) will be compared to a matched group of residents receiving standard treatment (N=36). Residents in the recovery-oriented treatment group are those whose key professionals have completed specific training on personal recovery. Residents will be matched by gender, age range, and DSM-5-TR diagnostic group. Regardless of the number of residents recruited in each diagnostic category, all matched residents will be included, as their placement in the same type of supported accommodation ensures comparability in functioning and care needs. Bio-psychosocial assessments of residents, their key professionals, and informal caregivers will be conducted at baseline and at two follow-up time points: six months and nine months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD Psychiatrist and clinical researcher

Study Record Dates

First Submitted

March 24, 2025

First Posted

April 6, 2025

Study Start

January 15, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

To promote open, transparent, and collaborative science, the raw data from all studies conducted at the IRCCS Fatebenefratelli will be published in publicly accessible repositories, as required by the scientific community and funding bodies, including the Ministry of Health and the European Commission. The raw clinical and biological data related to participants in this research, a non-randomized multicenter non-pharmacological clinical trial, will be published in a form that ensures the protection of participants' privacy in accordance with current regulations. Repositories will be selected that allow access to the information only after authentication of the access request and validation by the study responsible (or a designated representative) of the reasons for the request. The public repository will also be chosen based on the cybersecurity and data protection guarantees it offers.

Shared Documents
STUDY PROTOCOL
Time Frame
From December 2028 to Dcember 2029
Access Criteria
De-identified clinical and biological data from this non-randomized multicenter trial will be available in secure public repositories to support open science. * Eligibility: Access is granted for research aligned with study objectives, including secondary and meta-analyses. Requests must detail statistical methods, subject to independent review. * Privacy \& Security: Data will comply with protection regulations, stored only in repositories with strong cybersecurity measures. * Access Process: Researchers must submit a formal request and sign a Data Sharing Agreement (DSA) before access is granted. Authentication via the repository's system is required. * Review \& Approval: Requests will be evaluated by the study lead (or representative) based on scientific merit, ethical compliance, and feasibility.

Locations